Ultragenyx Pharmaceutical, Inc. (RARE)
22.47
-1.72
(-7.11%)
USD |
NASDAQ |
May 19, 16:00
22.47
0.00 (0.00%)
After-Hours: 20:00
Ultragenyx Pharmaceutical EPS Diluted (Quarterly) : -1.839 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 0.5022 |
| BioMarin Pharmaceutical, Inc. | 0.5431 |
| Regeneron Pharmaceuticals, Inc. | 6.752 |
| Xencor, Inc. | -1.713 |
| REGENXBIO, Inc. | -1.718 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -185.00M |
| Revenue (Quarterly) | 136.00M |
| Total Expenses (Quarterly) | 321.00M |
| Enterprise Value | 3.168B |
| Gross Profit Margin (Quarterly) | 72.06% |
| Profit Margin (Quarterly) | -136.0% |
| Earnings Yield | -27.17% |
| Normalized Earnings Yield | -27.19 |